%0 Journal Article %1 Lexchin2024 %A Lexchin, Joel %D 2023 %I American Medical Association (AMA) %K ClinicalBenefit DrugDevelopment marketing %N 1 %P 52 %R 10.1001/jamainternmed.2023.6256 %T Therapeutic Benefit From New Drugs From Pharmaceutical Companies %V 184

@article{Lexchin2024, added-at = {2024-01-04T11:24:47.000+0100}, author = {Lexchin, Joel}, biburl = {https://www.bibsonomy.org/bibtex/2daab4bdbcb7169a622dc704c5c78719c/jepcastel}, doi = {10.1001/jamainternmed.2023.6256}, interhash = {6e036143df752e70f9841c10d8615ded}, intrahash = {daab4bdbcb7169a622dc704c5c78719c}, issn = {2168-6106}, journaltitle = {JAMA Internal Medicine}, keywords = {ClinicalBenefit DrugDevelopment marketing}, number = 1, pages = 52, publisher = {American Medical Association (AMA)}, timestamp = {2024-01-04T11:24:47.000+0100}, title = {Therapeutic Benefit From New Drugs From Pharmaceutical Companies}, volume = 184, year = 2023 }